CC CELULARITY - Trademark Details
Status: 700 - Registered
Serial Number
88976214
Registration Number
5957944
Word Mark
CC CELULARITY
Status
700 - Registered
Status Date
2020-01-07
Filing Date
2018-06-27
Registration Number
5957944
Registration Date
2020-01-07
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2018-10-30
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
FALK, JONATHAN ROBERT
Statements
Indication of Colors claimed
The color(s) purple and green is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a purple tilted "C" next to a green backwards tilted "C" forming an infinity symbol above the word "CELULARITY" in purple.
Goods and Services
Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing written materials and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-07-01
Primary Code
042
First Use Anywhere Date
2018-05-16
First Use In Commerce Date
2018-05-16
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Camille M. Miller
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Parent | 88016661 |
Trademark Events
Event Date | Event Description |
2018-06-30 | NEW APPLICATION ENTERED IN TRAM |
2018-07-01 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-07-23 | ASSIGNED TO EXAMINER |
2018-07-24 | NON-FINAL ACTION WRITTEN |
2018-07-24 | NON-FINAL ACTION E-MAILED |
2018-07-24 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-08-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-08-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-08-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-08-30 | FINAL REFUSAL WRITTEN |
2018-08-30 | FINAL REFUSAL E-MAILED |
2018-08-30 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2018-09-04 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2018-09-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-09-05 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-09-08 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-09-23 | ASSIGNED TO LIE |
2018-10-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-10-30 | PUBLISHED FOR OPPOSITION |
2018-10-30 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2018-12-25 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-05-28 | TEAS EXTENSION RECEIVED |
2019-05-28 | EXTENSION 1 FILED |
2019-05-28 | EXTENSION 1 GRANTED |
2019-05-30 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-10-29 | TEAS STATEMENT OF USE RECEIVED |
2019-10-29 | TEAS REQUEST TO DIVIDE RECEIVED |
2019-11-08 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2019-10-29 | DIVISIONAL REQUEST RECEIVED |
2019-11-08 | DIVISIONAL PROCESSING COMPLETE |
2019-10-29 | USE AMENDMENT FILED |
2019-11-08 | STATEMENT OF USE PROCESSING COMPLETE |
2019-12-03 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2019-12-04 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2020-01-07 | REGISTERED-PRINCIPAL REGISTER |
2020-10-08 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2020-10-08 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2020-10-08 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-10-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-10-08 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2022-01-12 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |